Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer

被引：0
|
作者：
Danielsson, O. [1 ]
Dar, H. A. [1 ]
Nordenskjold, A. [2 ]
Tenorio, G. Perez [3 ,4 ]
Yau, C. [5 ]
Benz, C. [6 ]
Van't Veer, L. J. [7 ]
Esserman, L. [5 ]
Nordenskjold, B. A. [3 ,4 ]
Fornander, T. [1 ]
Stal, O. [3 ,4 ]
Tobin, N. P. [1 ]
Johansson, A. [1 ]
Lindstrom, L. S. [1 ]
机构：
[1] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden
[2] Sahlgrens Acad, Dept Oncol, Gothenburg, Sweden
[3] Linkoping Univ, Dept Biomed & Clin Sci, Linkoping, Sweden
[4] Linkoping Univ, Dept Oncol, Linkoping, Sweden
[5] UCSF Univ Calif San Francisco, Dept Surg, San Francisco, CA USA
[6] UCSF Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[7] UCSF Univ Calif San Francisco, Dept Lab Med, San Francisco, CA USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
基金：
瑞典研究理事会;
关键词：
D O I：
10.1016/j.annonc.2024.08.256
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315P
引用
收藏
页码：S346 / S346
页数：1
相关论文
共 50 条
  • [21] CYP2D6 and adjuvant tamoxifen: Impact on outcome in pre- but not postmenopausal breast cancer patients
    Margolin, S.
    Lindh, J.
    Thoren, L.
    Xie, H.
    Koukel, L.
    Dahl, M-L
    Eliasson, E.
    CANCER RESEARCH, 2012, 72
  • [22] Serum levels of the active tamoxifen metabolite Z-4OHtam is predictive of long-term survival in luminal B subtype of breast cancer patients
    Helland, Thomas
    Soiland, Havard
    Hustad, Steinar
    Lash, Timothy L.
    Kvaloy, Jan T.
    Renolen, Anne
    Borgen, Elin
    Bifulco, Ersilia
    Henne, Nina
    Lien, Ernst A.
    Mellgren, Gunnar
    Naume, Bjorn
    Janssen, Emiel A.
    CANCER RESEARCH, 2018, 78 (04)
  • [23] Modeling the effect of tamoxifen chemoprevention on long-term mortality in white women at high risk of breast cancer
    Maucort-Boulch, Delphine
    Roy, Pascal
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2006, 15 (04) : 347 - 352
  • [24] ENDOCRINOLOGY OF ADJUVANT CHEMOTHERAPY AND LONG-TERM TAMOXIFEN THERAPY IN PREMENOPAUSAL AND POSTMENOPAUSAL NODE POSITIVE BREAST-CANCER PATIENTS
    JORDAN, VC
    FRITZ, NF
    TORMEY, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1985, 6 (02) : 183 - 183
  • [25] ALTERNATING TAMOXIFEN AND MEDROXYPROGESTERONE ACETATE IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS - SHORT AND LONG-TERM ENDOCRINE EFFECTS
    CANOBBIO, L
    GALLIGIONI, E
    GASPARINI, G
    FASSIO, T
    CRIVELLARI, D
    VILLALTA, D
    SANTINI, G
    MONFARDINI, S
    BOCCARDO, F
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (02) : 201 - 204
  • [26] LONG-TERM TAMOXIFEN TREATMENT FOR BREAST-CANCER
    JORDAN, VC
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (23) : 1805 - 1806
  • [27] LONG-TERM TAMOXIFEN TREATMENT FOR BREAST-CANCER
    GREENSPAN, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (20) : 1559 - 1560
  • [28] Pre- and postmenopausal breast cancer risk in relation to physical activity.
    Thune, I
    Brenn, T
    Lund, E
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 282 - 282
  • [29] Lifetime physical activity and breast cancer risk in pre- and postmenopausal women
    Dorn, J
    Vena, J
    Brasure, J
    Freudenheim, J
    Graham, S
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2003, 35 (02): : 278 - 285
  • [30] Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women
    Stronegger, WJ
    Rasky, E
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (08) : 798 - 798
12345